Just when we were talking about delays keeping drug makers’ products from the U.S. market, GlaxoSmithKline announced that its cervical-cancer vaccine Cervarix may take even longer to get to the U.S. than expected.
The company said today that it wants to submit additional data to the FDA, and it now doesn’t expect an FDA decision before [...]
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment